832114-09-7 (2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯,1-methyl-4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine)

快速询单

结构式：

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯MOL文件

CAS号：

832114-09-7

中文名称：

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯

英文名称：

1-methyl-4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine

分子式：

C₁₆H₂₆BN₃O₂

分子量：

303.207543849945

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯(832114-09-7)名称与标识符

名称

中文别名：

1-甲基-4-[5-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-YL)吡啶-2-YL]哌嗪;1-甲基-5-[4-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)吡啶-2-基]哌嗪;2-(4-甲基哌嗪)吡啶-5-硼酸四甲基丙醇酯;2-(4-甲基哌嗪-1-基)吡啶-5-硼酸嚬哪醇酯;2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯;

英文别名：

1-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine;1-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)pyridin-2-yl)piperazine;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine;1-METHYL-5-[4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL]PIPERAZINE;2-(4-Methylpiperazin-1-yl)pyridine-4-boronic acid;2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID PINACOL ESTER;2-(4-Methylpiperazino)pyridine-4-boronic acid pinacol ester;Piperazine,1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]-;1-methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-piperazine;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine;1-Methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine;2-(2?HYDROXY-5?METHYLPHENYL)-BENZOTRIAZOLE;2-(4-Methylpiperazin-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-(4-methylpiperazin-1-yl)pyridine-4-boronic acid,pinacol ester;1-methyl-4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine;1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine (ACI);1-Methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridin-2-yl]piperazine;832114-09-7;1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-yl)piperazine;2-(4-Methylpiperazin-1-yl)pyridine-4-boronic acid pinacol ester;J-506074;SCHEMBL586733;EN300-212571;MFCD05864305;DTXSID10377755;CERIBIOLVVNLDM-UHFFFAOYSA-N;Z2050050097;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine, AldrichCPR;AB22753;FS-5917;1-methyl-4-[4(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine;2-(4-methylpiperazin-1-yl)pyridine-4-boronic acid, pinacol ester;1-methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)-pyridin-2-yl]-piperazine;AKOS015947258;2-(4-Methylpiperizinyl)pyridine-4-boronic acid pinacol ester;

标识符

MDL：

MFCD05864305

InChIKey：

CERIBIOLVVNLDM-UHFFFAOYSA-N

Inchi：

1S/C16H26BN3O2/c1-15(2)16(3,4)22-17(21-15)13-6-7-18-14(12-13)20-10-8-19(5)9-11-20/h6-7,12H,8-11H2,1-5H3

SMILES：

N1C(N2CCN(C)CC2)=CC(B2OC(C)(C)C(C)(C)O2)=CC=1

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯(832114-09-7)物化性质

实验特性

LogP : 1.13550
PSA : 37.83000
熔点 : 125.0-125.7°C

计算特性

精确分子量 : 303.21200
氢键供体数量 : 0
氢键受体数量 : 5
可旋转化学键数量 : 2
同位素质量 : 303.2118072g/mol
重原子数量 : 22
复杂度 : 381
同位素原子数量 : 0
确定原子立构中心数量 : 0
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
拓扑分子极性表面积 : 37.8Å²

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯(832114-09-7)安全信息

安全说明： S26; S36
风险术语： R36/37/38
危害声明：H315; H319; H335
警示性声明：P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
储存条件： Store at room temperature
危险类别码： 36/37/38
信号词： Warning

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯(832114-09-7)海关数据

海关编码：

2934999090

海关数据：

中国海关编码：

2934999090

概述：

2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素：

品名, 成分含量, 用途

Summary：

2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯(832114-09-7)推荐厂家更多厂家(9)

公司名称	手机号/电话	联系人	QQ	询单
上海楷森生物科技有限公司	17558870519 175-58870519	赵经理	3003926540	询单
赫澎（上海）生物科技有限公司	13122891558 186-16545970	张硕	3418426269	询单
上海绩祥生物科技有限公司	13093077543	陆经理	3985448220	询单
上海一基实业有限公司	13311756052 021-60526763 13311756052 13311756131	胡经理	2355265332	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
金锦乐（湖南）化学有限公司		金锦乐	1226360695	询单
江苏艾康生物医药研发有限公司	18795912720 025-66061636	杨情情	3004779232	询单
江苏倍达医药科技有限公司	18994340901 0512-63009836	贺慧	540534176	询单
上海源叶生物科技有限公司	15026964105 15026964105	汤思磊	2881489226	询单

2-(4-甲基哌嗪-1-基)吡啶-5-硼酸频哪醇酯(832114-09-7) MSDS

基础信息

Material Safety Data Sheet

Section 1. Identi?cation of the substance
Product Name: 2-(4-Methylpiperazino)pyridine-4-boronic acid pinacol ester
Synonyms: 1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine

Section 2. Hazards identi?cation
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-(4-Methylpiperazino)pyridine-4-boronic acid pinacol ester
CAS number: 832114-09-7

Section 4. First aid measures
    Skin contact:        Immediately wash skin with copious amounts of water for at least 15 minutes while removing
    contaminated clothing and shoes. If irritation persists, seek medical attention.
    Eye contact:        Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
    ?ushing of the eyes by separating the eyelids with ?ngers. If irritation persists, seek medical
    attention.
    Inhalation:        Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
    Ingestion:        Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire ?ghting measures
    In the event of a ?re involving this material, alone or in combination with other materials, use dry
    powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
    should be worn.

Section 6. Accidental release measures
    Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
    standards.
    Respiratory precaution:        Wear approved mask/respirator
    Hand precaution:        Wear suitable gloves/gauntlets
    Skin protection:        Wear suitable protective clothing
    Eye protection:        Wear suitable eye protection
    Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
    for disposal. See section 12.
    Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
    Handling:        This product should be handled only by, or under the close supervision of, those properly quali?ed
    in the handling and use of potentially hazardous chemicals, who should take into account the ?re,
    health and chemical hazard data given on this sheet.
    Store in closed vessels, under ?20?C.
    Storage:

Section 8. Exposure Controls / Personal protection
    Engineering Controls: Use only in a chemical fume hood.
    Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
    General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
    Appearance:        Not speci?ed
    Boiling point:        No data
    No data
    Melting point:
    Flash point:        No data
    Density:        No data
    Molecular formula:        C16H26BN3O2
    Molecular weight:        303.2

Section 10. Stability and reactivity
    Conditions to avoid: Heat, ?ames and sparks.
    Materials to avoid: Oxidizing agents.
    Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
    No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
    302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
    Title III, Section 313.

SECTION 16 - ADDITIONAL INFORMATION
N/A